November 15th 2024
Here is some of the most popular content posted on LCGC International this week.
A New Frontier: NanoLC–NanoESI–MS in Astrobiology
March 20th 2014Mike Callahan, an analytical chemist at NASA's Goddard Space Flight Center (Maryland, USA), led a team to develop a new nano LC–nano ESI–MS method to detect life's building blocks in "spacedust". Callahan spoke to The Column about the inspiration behind the project, the challenges of analyzing extraterrestrial material in the laboratory, and future directions.
Principal Component Analysis with LC–MS Enhances Natural Drug Discovery Process
March 10th 2014Scientists in Malaysia have developed a useful metabolomics approach that could aid analysts working in natural drug discovery. The team applied liquid chromatography–mass spectrometry (LC–MS) coupled with principle component analysis (PCA) to screen more than 4000 natural extracts for novel photosensitizer drugs.
The Evolution of Chiral Stationary Phases from HPLC to UHPLC
This article focuses on the progression that chiral stationary phases (CSPs), specifically developed for HPLC, are currently undergoing because of the pressing need of an easy switch to UHPLC.
Efficient and Sensitive Determination of "Corky" and Other Off-Flavours in Wine
January 9th 2014To ensure an efficient, reliable, and sensitive determination of all corkiness-related off-flavour compounds in wine samples, the DLR Mosel in Germany has successfully turned to GC–MS combined with stir-bar sorptive extraction.
Optimizing LC–MS and LC–MS–MS Methods
January 1st 2014Secondary parameters in the interface and mass analyzer can often have a major impact on sensitivity and reproducibility. This column considers how and when to consider optimizing these parameters through a study of the working principles of LC–MS analysis.
Methamphetamine Analogue Found in Dietary Supplement
November 6th 2013Potentially dangerous levels of the methamphetamine analogue, N, ??diethyl?phenylethylamine (N, ? -DEPEA), have been detected in a widely available dietary supplement using ultrahigh-pressure liquid chromatography coupled to mass spectrometry (UHPLC–MS). The supplement, Craze, can be bought in the USA and from on-line retailers. The findings have been published in the journal Drug Testing and Analysis by a team of scientists from Harvard Medical School (Massachusetts, USA), NSF International (Missouri, USA), and the National Institute for Public Health and the Environment Health Protection Center (Bilthoven, The Netherlands).1
The Current Status and Future of LC Column Technology: What the Experts Are Saying
August 1st 2013A summary of the results from a survey of 14 leading HPLC–UHPLC column experts is presented, covering the state of sub-2-?m porous particles, superficially porous (core–shell) particles, silica monoliths, and polymeric monoliths.
How UHPLC and Large Molecules Fit Together
July 5th 2013The use of UHPLC has triggered a remarkable increase in efficiency and throughput of LC and LC –MS methods. The fastest growing market segment in the pharmaceutical industry is biopharmaceuticals, with an increased interest in applying UHPLC to biopharmaceutical analysis.